By examining the issue of the thromboses and hemostasis disorders associated with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) through the lens of cross-reactivity, it was found that 60 pentapeptides are shared by SARS-CoV-2 spike glycoprotein (gp) and human proteins that— when altered, mutated, deficient or, however, improperly functioning— cause vascular diseases, thromboembolic complications, venous thrombosis, thrombocytopenia, coagulopathies, and bleeding, inter alia. The peptide commonality has a relevant immunological potential as almost all of the shared sequences are present in experimentally validated SARS-CoV-2 spike gp-derived epitopes, thus supporting the possibility of cross-reactions between the viral gp and the thromboses-related human proteins. Moreover, many of the shared peptide sequences are also present in pathogens to which individuals have previously been exposed following natural infection or vaccinal routes, and of which the immune system has stored imprint. Such an immunological memory might rapidly trigger anamnestic secondary cross-reactive responses of extreme affinity and avidity, in this way explaining the thromboembolic adverse events that can associate with SARS-CoV-2 infection or active immunization.
【저자키워드】 COVID-19, cross-reactivity, bleeding, vascular diseases, SARS-CoV-2 spike gp, immunological imprinting, thromboses-related proteins, thromboses, 【초록키워드】 SARS-CoV-2, Diseases, SARS-COV-2 infection, peptide, immune system, Immunological memory, immunization, Hemostasis, Epitopes, pathogen, SARS-CoV-2 spike glycoprotein, response, adverse event, Venous thrombosis, natural infection, Coagulopathies, cross-reaction, SARS-CoV-2 spike, cross-reactive, thromboembolic, Vascular, individual, sequence, human proteins, disorder, thromboembolic complications, vaccinal, immunological, commonality, extreme, mutated, human protein, pentapeptide, 【제목키워드】 Imprinting, role, Causal,